|
|
|
Volumn 11, Issue 4, 2006, Pages 72-
|
|
Antiretroviral resistance
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIRETROVIRUS AGENT;
DIDANOSINE;
EFAVIRENZ;
EMTRICITABINE;
GAG PROTEIN;
LAMIVUDINE;
PROTEINASE;
PROTEINASE INHIBITOR;
RITONAVIR;
RNA DIRECTED DNA POLYMERASE;
RNA DIRECTED DNA POLYMERASE INHIBITOR;
TENOFOVIR;
VIRUS RNA;
CLINICAL TRIAL;
DRUG SENSITIVITY;
EDITORIAL;
GENE MUTATION;
GENE SEQUENCE;
GENETIC VARIABILITY;
GENOTYPE;
HIGHLY ACTIVE ANTIRETROVIRAL THERAPY;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS 1;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
PHENOTYPE;
PREVALENCE;
REAL TIME POLYMERASE CHAIN REACTION;
TREATMENT FAILURE;
VIRUS DETECTION;
VIRUS GENE;
VIRUS LOAD;
VIRUS REPLICATION;
ANTI-HIV AGENTS;
ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE;
DRUG RESISTANCE, VIRAL;
HIV INFECTIONS;
HIV-1;
HUMANS;
MICROBIAL SENSITIVITY TESTS;
REVERSE TRANSCRIPTASE INHIBITORS;
RNA, VIRAL;
VIRAL LOAD;
|
|
EID: 33846648070
PISSN: 14620308
EISSN: None
Source Type: Journal
DOI: None Document Type: Editorial |
|
Times cited : (2)
|
|
References (0)
|
